- Home
- Publications
- Publication Search
- Publication Details
Title
CEACAM1: Expression and Role in Melanocyte Transformation
Authors
Keywords
-
Journal
DISEASE MARKERS
Volume 2016, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2016-08-25
DOI
10.1155/2016/9406319
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors
- (2016) SABINA ZURAC et al. Oncology Letters
- SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells
- (2016) Shira Ashkenazi et al. Oncotarget
- Chemokines in the Melanoma Metastasis Biomarkers Portrait
- (2015) Monica Neagu et al. JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY
- MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanoma
- (2015) Nico Ullrich et al. Pigment Cell & Melanoma Research
- Antagonistic Cross-Regulation between Sox9 and Sox10 Controls an Anti-tumorigenic Program in Melanoma
- (2015) Olga Shakhova et al. PLoS Genetics
- A longitudinal study of CEACAM1 expression in melanoma disease progression
- (2014) DOUGLAS ZIPPEL et al. ONCOLOGY REPORTS
- CEACAM1 Promotes Melanoma Cell Growth through Sox-2
- (2014) Rona Ortenberg et al. NEOPLASIA
- Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis
- (2013) Nicole Beauchemin et al. CANCER AND METASTASIS REVIEWS
- Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring
- (2013) Amanda Bulman et al. Current Proteomics
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Immune Parameters in The Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations
- (2013) Monica Neagu et al. Biomed Research International
- CEACAM1 inhibits cell-matrix adhesion and promotes cell migration through regulating the expression of N-cadherin
- (2012) Jin Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients
- (2012) Sapoznik Sivan et al. Clinical & Developmental Immunology
- CEACAM1 in Malignant Melanoma: A Diagnostic and Therapeutic Target
- (2012) S. Sapoznik et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas
- (2012) Pei-Ling Chen et al. MODERN PATHOLOGY
- Novel Immunotherapy for Malignant Melanoma with a Monoclonal Antibody That Blocks CEACAM1 Homophilic Interactions
- (2012) Rona Ortenberg et al. MOLECULAR CANCER THERAPEUTICS
- Plasma Markers for Identifying Patients with Metastatic Melanoma
- (2011) H. M. Kluger et al. CLINICAL CANCER RESEARCH
- SOX2 contributes to melanoma cell invasion
- (2011) Sasha D Girouard et al. LABORATORY INVESTIGATION
- Melanoma-associated antigen genes – An update
- (2010) Meixiang Sang et al. CANCER LETTERS
- Protein Expression of Carcinoembryonic Antigen Cell Adhesion Molecules in Benign and Malignant Melanocytic Skin Lesions
- (2009) Thilo Gambichler et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Systemic dysregulation of CEACAM1 in melanoma patients
- (2009) Gal Markel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)
- (2009) Sanjiv S. Agarwala et al. EUROPEAN JOURNAL OF CANCER
- Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid
- (2009) Thierry Passeron et al. JOURNAL OF CLINICAL INVESTIGATION
- Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse
- (2009) Friederike Egberts et al. MELANOMA RESEARCH
- Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack
- (2008) Gal Markel et al. IMMUNOLOGY
- The CEACAM1-mediated apoptosis pathway is activated by CEA and triggers dual cleavage of CEACAM1
- (2008) S Nittka et al. ONCOGENE
- CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium
- (2008) H Zalzali et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now